Celsion completes OVATION study and provides update on advanced stage III and IV Ovarian Cancer; shares ahead 34% premarket [Seeking Alpha]
Celsion Corporation (CLSN)
Last celsion corporation earnings: 11/14 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.celsion.com/investor-relations
Company Research
Source: Seeking Alpha
Celsion Corporation (NASDAQ: CLSN ) provides an update on its Phase Ib dose escalating clinical trial (the OVATION Study) combining GEN-1 with neoadjuvant chemotherapy for the treatment of patients with Stage III and IV ovarian cancer followed by interval debulking surgery. Enrollment got complete in the OVATION study. The clinical findings from the study enrolling 14 patients are as follows: 86% Objective Response Rate (ORR) in Phase IB dose escalating study. 100% ORR and 100% R0 (Margin Negative) surgical resection rate at highest dose cohort. Final translational research data is being collected and will be available in Q3 for evaluation. Previous research findings from the first four patient cohorts are as below: The ratio of CD8+ cells to immunosuppressive cells was increased in ~75% of patients suggesting an overall shift in the immune environment to pro-immune stimulatory following treatment with GEN-1. This increase is believed to be a good predictor of b
Show less
Read more
Impact Snapshot
Event Time:
CLSN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLSN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLSN alerts
High impacting Celsion Corporation news events
Weekly update
A roundup of the hottest topics